Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06816342Phase 4Recruiting
Phase 4, open-label trial in asthma (10 arms), sponsored by Beni Suef University. Primary endpoints: Total Emitted Dose (TED) at 3 months, Mass Median Aerodynamic Diameter at 3 months and 4 more. Started Nov 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06816342.